LimFlow System
FDA premarket approval P220025/S001 · decided 2023-10-12
Approval details
- PMA number
- P220025
- Supplement
- S001
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Postapproval Study Protocol
- Trade name
- LimFlow System
- Generic name
- Stent graft, infrapopliteal, venous arterialization
- Applicant
- LimFlow, Inc.
- Date received
- 2023-09-15
- Decision date
- 2023-10-12
- Days to decision
- 27 days
- Decision code
- APPR
- Product code
- QWN
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- San Jose, CA
- Statement
- Approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220025.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| LimFlow Vector (K260188) | LimFlow, Inc. | 2026-03-18 |
| LimFlow ARC (K251376) | LimFlow, Inc. | 2025-05-31 |
| LimFlow V-Ceiver (K242776) | LimFlow, Inc. | 2025-02-14 |
| LimFlow Vector (K221902) | LimFlow, Inc. | 2022-12-21 |
| LimFlow ARC (K221541) | LimFlow, Inc. | 2022-08-31 |
| LimFlow V-Ceiver (K222083) | LimFlow, Inc. | 2022-08-09 |